Notably, MCC950 administration concurrent with adenine diet initiation attenuates renal fibrosis by inhibiting NLRP3 inflammasome activation, whereas delayed MCC950 treatment on day 7 of the diet fails to confer protection (80), underscoring the therapeutic necessity of early intervention to suppress inflammation and fibrosis progression. This evidence concerns the gene NLRP3 and renal fibrosis.